CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 134 enrolled
Drug / intervention
Bupivacaine +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03084536
NCT03084536Phase 2Completed

PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

Washington University School of Medicine·interventional·Posted Mar 21, 2017·Updated Dec 24, 2024

In Brief

A Phase 2 clinical trial evaluating Bupivacaine, Gabapentin, and 4 other interventions for Breast Cancer and 2 related conditions. Completed, enrolled 134 participants across 1 site.

Detailed Summary

In this double blinded randomized placebo-controlled trial, 160 subjects scheduled for breast surgery involving the axilla will be administered a multimodal pain regimen including acetaminophen, dexamethasone, celecoxib, and gabapentin. 80 subjects will also receive a Pectoral Nerve blocks I and II (PECS I and II block) preoperatively.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 21, 2017
Enrollment StartJun 7, 2017
Primary CompletionFeb 25, 2021
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 9.3 years ago

Interventions

Bupivacainedrug

-Given after general anesthesia

Gabapentindrug

* As per routine care * Will not be prescribed for any patient with preexisting kidney disease or ≥ 65 years.

Celecoxibdrug

* As per routine care * Will not be prescribed for any patient with preexisting kidney disease or ≥ 65 years. * Naproxen will be substituted for celecoxib in patients with sulfa allergies.

Acetaminophendrug

-As per routine care

Midazolamdrug

-As per routine care

Fentanyldrug

-As per routine care